Healthcare


 Sigma Healthcare Faces Share Pressure Despite Strong Earnings Post-Merger; ASX200 Implications in Focus

Sigma Healthcare Faces Share Pressure Despite Strong Earnings Post-Merger; ASX200 Implications in Focus

May 06, 2025 02:32 PM AEST| By Team Kalkine Media

Highlights,Sigma posts 36% EBIT growth after Chemist Warehouse merger,Share price slips following earnings and conference presentation,Transaction costs weigh on investor sentiment,Shares of,Sigma Healthcare (ASX:SIG),came under pressure in early tra...

 Emyria Limited (ASX:EMD) Share Activity Reviewed Amid ASX 200 and Health Sector Focus

Emyria Limited (ASX:EMD) Share Activity Reviewed Amid ASX 200 and Health Sector Focus

May 06, 2025 02:31 PM AEST| By Team Kalkine Media

Highlights,Emyria Limited shares experienced notable upward movement in recent sessions,Company insiders reported significant equity interest over the past year,Trading records show higher share acquisitions than disposals overall,Emyria Limited (ASX...

 Why CSL (ASX:CSL) Remains a Healthcare Powerhouse in the ASX200 Amid Shifting Markets

Why CSL (ASX:CSL) Remains a Healthcare Powerhouse in the ASX200 Amid Shifting Markets

May 06, 2025 01:20 PM AEST| By Team Kalkine Media

Highlights,CSL’s diversified healthcare model supports consistent performance,Global healthcare demand continues to climb, offering sector tailwinds,Dividend growth supports CSL’s reputation among ASX dividend stocks,CSL Limited (ASX:CSL), a global l...

 Sigma Healthcare Merger Boosts Earnings Amid ASX200 Spotlight

Sigma Healthcare Merger Boosts Earnings Amid ASX200 Spotlight

May 06, 2025 12:35 PM AEST| By Team Kalkine Media

Highlights,Sigma earnings up 36% in nine months,$42.4 million merger transaction costs recorded,New,$36 billion,group now includes,nearly 1,000,stores,Sigma Healthcare (ASX:SIG) has reported a robust 36% surge in pre-tax earnings for the nine months...

 CSL Faces US Vaccination Headwinds, Eyes Growth in Europe Amid ASX200 Spotlight

CSL Faces US Vaccination Headwinds, Eyes Growth in Europe Amid ASX200 Spotlight

May 06, 2025 12:33 PM AEST| By Team Kalkine Media

Highlights,CSL sees US vaccine reluctance as a pricing challenge,Growth momentum picking up in Germany and France,Flu season impact uncertain due to shifting US political stance,CSL Limited (ASX:CSL),is navigating a complex environment in the United...

 Chemist Warehouse Faces Global Hurdles: Sigma Healthcare Outlook Steady Amid ASX200 Performance

Chemist Warehouse Faces Global Hurdles: Sigma Healthcare Outlook Steady Amid ASX200 Performance

May 06, 2025 12:21 PM AEST| By Team Kalkine Media

Highlights,Chemist Warehouse,maintains,strong local momentum,Global growth outlook raises caution,Sigma earnings align with expectations,Despite maintaining local dominance, the international expansion story for Chemist Warehouse under Sigma Healthca...

 Fonterra (ASX:FCG) Seeks Clarity in Dispute with Bega, Aims for ASX200 Listing and Strong Divestment Strategy

Fonterra (ASX:FCG) Seeks Clarity in Dispute with Bega, Aims for ASX200 Listing and Strong Divestment Strategy

May 06, 2025 12:16 PM AEST| By Team Kalkine Media

Highlights,Fonterra appeals court ruling over Bega Cheese brand agreement.,Plans to pursue both trade sale and IPO for its Mainland business.,The decision impacts Fonterra’s future in the ASX200 and ASX dividend stocks.,Fonterra (ASX:FCG) has announc...

 CSL Limited: Key Updates from Recent Shareholder Meeting & Technology Developments | ASX 200

CSL Limited: Key Updates from Recent Shareholder Meeting & Technology Developments | ASX 200

May 06, 2025 08:32 AM AEST| By Team Kalkine Media

Highlights:,CSL Limited's share price increased following a recent shareholder meeting.,The company’s total shareholder return faced a decline over the past three years.,CSL is advancing in iNOMi and HEMGENIX technologies for future growth.,CSL Limit...

 Immutep’s Breakthrough Immunotherapy Delivers Strong Survival Gains in ASX200 Cancer Trial

Immutep’s Breakthrough Immunotherapy Delivers Strong Survival Gains in ASX200 Cancer Trial

May 05, 2025 02:54 PM AEST| By Team Kalkine Media

Highlights,Strong survival outcomes in head and neck cancer trial,Potential step forward in chemotherapy-free immunotherapy,Addresses high unmet need in immune-resistant tumours,Immutep (ASX:IMM),has released promising results from its Phase IIb TACT...

 Can Sonic Healthcare’s ROE Trends Reflect Broader ASX200 Healthcare Sector Signals?

Can Sonic Healthcare’s ROE Trends Reflect Broader ASX200 Healthcare Sector Signals?

May 05, 2025 02:32 PM AEST| By Team Kalkine Media

Can Sonic Healthcare’s ROE Trends Reflect Broader ASX200 Healthcare Sector Signals?

 Healius Boosts Shareholder Returns with $300 Million Special Dividend: A Positive Signal in ASX200

Healius Boosts Shareholder Returns with $300 Million Special Dividend: A Positive Signal in ASX200

May 05, 2025 02:30 PM AEST| By Team Kalkine Media

Highlights,Healius announces fully franked special dividend.,Distribution totals approximately $300 million.,Share price rises over 4% following announcement.,Healthcare and diagnostic services provider,Healius,(ASX:HLS) has announced a significant m...

 Cadoux (ASX:CDX) Powers Ahead in HPA and Rare Earths with Strategic Moves and ASX200 Growth Potential

Cadoux (ASX:CDX) Powers Ahead in HPA and Rare Earths with Strategic Moves and ASX200 Growth Potential

May 05, 2025 12:53 PM AEST| By Team Kalkine Media

Highlights,FEED studies initiated for high purity alumina plant,Minhub feasibility study completed in Darwin,Focus on EV, battery, and rare earth market demand,Cadoux Ltd (ASX:CDX),made notable strides during the March 2025 quarter, progressing its H...

 Biotech Breakthrough and ASX 200 Movement: ATH, GOR, HZR Drive Industry Updates

Biotech Breakthrough and ASX 200 Movement: ATH, GOR, HZR Drive Industry Updates

May 05, 2025 11:30 AM AEST| By Team Kalkine Media

Highlights,Alterity Therapeutics (ASX:ATH) receives Fast Track designation from the U.S. FDA for a rare neurological disorder treatment,Gold Road Resources (ASX:GOR) enters strategic agreement with Gold Fields to advance sector consolidation,Hazer Gr...

 Alterity Therapeutics (ASX:ATH) Gains FDA Fast-Track Status Amid ASX 200 Biotech Developments

Alterity Therapeutics (ASX:ATH) Gains FDA Fast-Track Status Amid ASX 200 Biotech Developments

May 05, 2025 11:30 AM AEST| By Team Kalkine Media

Highlights:,Alterity Therapeutics (ASX:ATH) received FDA fast-track designation for its neurological therapy ATH434,Trading volume surged on the ASX and NASDAQ amid high share activity,Biotech sector, including Alterity, aligns with broader developme...

 Why Cochlear (ASX:COH) May Be a Standout in ASX200 Healthcare Stocks in 2025

Why Cochlear (ASX:COH) May Be a Standout in ASX200 Healthcare Stocks in 2025

May 05, 2025 10:41 AM AEST| By Team Kalkine Media

Highlights,COH shares trade below historical valuation,Healthcare sector shows stable, long-term potential,Growing appeal for ethical and sustainable investing,Cochlear (ASX:COH), the global leader in hearing implant technology, has seen its share pr...

 Key Insider Activity at Althea Group Holdings (ASX:AGH) – Insight on Recent Developments

Key Insider Activity at Althea Group Holdings (ASX:AGH) – Insight on Recent Developments

May 03, 2025 02:34 PM AEST| By Team Kalkine Media

Highlights:,CEO Joshua Fegan made a significant stock purchase in Althea Group Holdings (ASX:AGH).,Over the last year, the company experienced a net buying trend in insider transactions.,Despite strong insider alignment, there are notable concerns re...

 Sigma Healthcare's Post-Merger Momentum: What's Driving Investor Interest in this ASX200 Stock

Sigma Healthcare's Post-Merger Momentum: What's Driving Investor Interest in this ASX200 Stock

May 02, 2025 04:01 PM AEST| By Team Kalkine Media

Highlights,Sigma Healthcare's growth outlook shines post-Chemist Warehouse merger,Valuation premium seen as justified by strong defensive earnings,11% upside potential highlighted by analysts,Sigma Healthcare (ASX:SIG) is gaining renewed attention fo...

 Island Pharmaceuticals ASX:ILA Transactions: Ownership and Share Trends Reviewed | ASX All Ordinaries & ASX 200

Island Pharmaceuticals ASX:ILA Transactions: Ownership and Share Trends Reviewed | ASX All Ordinaries & ASX 200

May 02, 2025 02:35 PM AEST| By Team Kalkine Media

Highlights,Market capitalization increased significantly for Island Pharmaceuticals (ASX:ILA) during the year,Company insiders showed more buying activity than selling over the review period,Ownership by company insiders remains a substantial portion...

 Ownership Breakdown of Healius Limited (ASX:HLS) and Its Market Dynamics

Ownership Breakdown of Healius Limited (ASX:HLS) and Its Market Dynamics

May 02, 2025 02:32 PM AEST| By Team Kalkine Media

Highlights,:,Institutional investors own a major portion of Healius.,Private equity firms possess a significant stake in the company.,Insiders and the general public hold relatively smaller shares,Healius Limited (ASX:HLS) is a key player in the heal...

 Is Biotech Volatility Reshaping Imugene's Path in the ASX All Ordinaries Index?

Is Biotech Volatility Reshaping Imugene's Path in the ASX All Ordinaries Index?

May 02, 2025 01:30 PM AEST| By Team Kalkine Media

Is Biotech Volatility Reshaping Imugene's Path in the ASX All Ordinaries Index?

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.